Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants Better survival in one registry study, detriment with class I HLA mismatch in another Aug 27, 2024
FDA Could Soon Limit Use of Only Drug for COVID Prevention Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns Aug 27, 2024
Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care Findings from my recent study shook me to my core Aug 26, 2024
Adding MRI to DBT Screening in Women With Dense Breasts May Avert More Cancer Deaths But benefit in modeling study accompanied by more false-positive biopsy recommendations Aug 26, 2024
King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer? Health news and commentary gathered by Ƶ staff Aug 26, 2024
The Global Fight Against Infection-Driven Cancers Despite vast gains in knowledge, there's still much to do if we want to save lives Aug 25, 2024
Amino Acids May Protect Kidneys During Surgery; EDTA for Chelation Therapy Also in TTHealthWatch: suicidality among spouses of people with cancer Aug 24, 2024 podcast
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer News, features, and commentary about cancer-related issues Aug 23, 2024
HPV Vaccine Coverage in Teens Stalled for Second Straight Year, CDC Says And being up-to-date on HPV vaccination by age 13 fell among kids born in 2010 Aug 23, 2024
Favorable Outcomes With Microwave Ablation for Colorectal Liver Metastases Survival similar to resection with less morbidity, but editorial suggests use in select patients Aug 22, 2024
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity Aug 22, 2024
Doc Never Heard Patient's Screams; How Richard Simmons Died; Suicides in Physicians Health news and commentary gathered by Ƶ staff Aug 22, 2024
Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients Troublesome side effects, barriers to access could limit future availability Aug 21, 2024
Strong Support for Not Interrupting Imatinib Treatment in Advanced GIST Worse progression-free, overall survival, shorter time to resistance after discontinuation Aug 20, 2024
Researchers Challenge USPSTF's Lung Cancer Screening Criteria Alternate criteria based on years of smoking has higher sensitivity and specificity, study says Aug 20, 2024
Dose-Reduced Chemo Regimen Promising in Metastatic Pancreatic Cancer Alternating cycles of nab-paclitaxel-gemcitabine and gemcitabine alone boosted tolerability Aug 20, 2024
Evidence Still Lacking for Iron Deficiency Screening, Supplementation in Pregnancy USPSTF says new findings were consistent with those of previous review Aug 20, 2024
Traveling to Die: The Latest Form of Medical Tourism Patients with terminal illness explore end-of-life options Aug 20, 2024
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib Aug 20, 2024
Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggests More data for discussion of controversial association between steroids, immunotherapy Aug 19, 2024
No Effect of Tranexamic Acid on Bleeding in Surgery for Liver Cancer No difference from placebo in transfusion rate, blood loss, with higher complication rate Aug 19, 2024
Confirmed Antitumor Activity With T-DXd for HER2-Positive Metastatic CRC Overall response rate approaching 40%, including hard-to-treat RAS-mutant tumors Aug 16, 2024
Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. Reactions from physician and consumer groups were positive, but drugmakers begged to differ Aug 16, 2024
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer News, features, and commentary about cancer-related issues Aug 16, 2024
FDA Expands Durvalumab Label to Operable Lung Cancer PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery Aug 16, 2024
'SNL' Alum's Inoperable Cancer; Viral Toddler Checkup; Rocket Fuel Chemical in Food Health news and commentary gathered by Ƶ staff Aug 16, 2024
Benefits of Adjuvant RT for Early Breast Cancer Limited to First 10 Years A study's 30-year follow-up data provided no new insights into which patients benefit from RT Aug 15, 2024
Spouses of Cancer Patients May Be at Increased Risk of Suicide Risk was highest in the year following spouse's diagnosis Aug 15, 2024
Kate Middleton Update; First Mask Ban in U.S.; Sudden Cardiac Arrest Survival Health news and commentary gathered by Ƶ staff Aug 15, 2024
Novel Agent for Chronic GVHD Wins FDA Approval Axatilimab achieved a 75% response rate in patients with previously treated chronic GVHD Aug 14, 2024
A Win for Molecularly Guided Therapy for Cancer of Unknown Primary Improved PFS versus chemotherapy adds to evidence that could lead to practice change Aug 14, 2024
Blood Test for Colon Cancer: Panacea or Hype? This newly approved testing modality brings challenges and opportunities Aug 14, 2024
CDC Alerts on Dramatic Rise in Human Parvovirus B19 Pregnant people and those who are immunocompromised most at risk, agency warns Aug 14, 2024
Eight Doctors Killed in Brazil's Horrifying Plane Crash "They were people used to saving lives, and now they lost theirs in such tragic circumstances" Aug 13, 2024
Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised? Health news and commentary gathered by Ƶ staff Aug 13, 2024
Methotrexate for Knee Osteoarthritis; Evaluating Squamous Cell Cancers Also in TTHealthWatch: blood tests for Alzheimer's Aug 10, 2024 podcast
Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer Researchers suggest unfavorable risk-benefit ratio "disqualifies" it as a staging tool Aug 09, 2024
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire News, features, and commentary about cancer-related issues Aug 09, 2024
Outcomes in Resected Melanoma Influenced by Timing of Recurrence Early recurrence after anti-PD-1/L1 likely to benefit more from anti-CTLA-4, targeted agents Aug 08, 2024